HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Lithium Citrate

HCID 13520
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
10377-38-5
Standard SMILES
O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[Li+].[Li+].[Li+]
InChIKey
WJSIUCDMWSDDCE-UHFFFAOYSA-K
Molecular formula
C6H5Li3O7
Average molar mass
210 g/mol
Monoisotopic mass
210.0515378

Overview

Lithium Citrate can cause developmental toxicity according to state or federal government labeling requirements.

Names & identifiers

Preferred name
Lithium Citrate
IUPAC
trilithium;2-hydroxypropane-1,2,3-tricarboxylate
English name
citric acid, lithium salt
Molecular formula
C6H5Li3O7
Molecular weight
209.9227

Names & synonyms

Lithium citrateLitarexCITRIC ACID, TRILITHIUM SALTLithium Citrate (anhydrous)anhydrous lithium citrateCHEBI:64735Lithium (as citrate)CHEBI:64754NSC-758700Li-liquidRefChem:55514trilithium(1+) 2-hydroxypropane-1,2,3-tricarboxylate
Show more names
Einecs 233-819-9citric acid, lithium salt2-Hydroxy-1,2,3-propanetricarboxylic acid/lithium,(1:x) salt
5Z6E9K79YVLithonate S919-16-4Trilithium citrateCitric acid trilithium saltLithium citrate anhydrousLithium (Citrate)1,2,3-Propanetricarboxylic acid, 2-hydroxy-, trilithium salt

Database identifiers

CAS
10377-38-5、313222-91-2、6080-58-6、919-16-4
PubChem CID
13520
DTXSID
DTXSID70883185
ChEMBL
CHEMBL1201170、CHEMBL2103738
ChEBI
CHEBI:64735

Properties

Computed structural properties

Topological polar surface area
141 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
7
Rotatable bonds
2
Heavy atoms
16
Formal charge
0
Complexity
211

Experimental & physicochemical properties

Chemical ClassesMetals -> Organic Acids, Metal Salts
Human Drugs · 2 items

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Physical DescriptionTetrahydrate: White deliquescent solid; [Merck Index]

Physicochemical properties

HS Code
2918150000 · 2918150000

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 6 items

Warning

H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]

P264+P265, P280, P305+P351+P338, and P337+P317 (click each P-code to see the statement)

Aggregated GHS information provided per 38 reports by companies from 1 notifications to the ECHA C&L Inventory.

This chemical does not meet GHS hazard criteria for 96.4% (27 of 28) of all reports.

Not Classified

Hazard information

Regulatory Information · 4 items

Chemical: 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, trilithium salt

Hazard Traits - Developmental Toxicity

REACH registered substance: Lithium citrate (EC: 612-032-8)

Lithium citrate: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, trilithium salt: Human health tier I assessment
Hazards SummaryMay cause eye irritation; [GFS Chemicals MSDS] See Lithium.
Hazard Classes and Categories · 2 items

Not Classified

Eye Irrit. 2 (100%)

Safety & protection

Exposure Control and Personal Protection0.2 [mg/m3], inhalable fraction, as Li[German Research Foundation (DFG)]

Toxicology

Chemistry & industry

Pharmacology

Pharmacodynamics · 1 item

Although lithium has been used for over 50 years in treatment of bipolar disorder, the mechanism of action is still unknown. Lithium's therapeutic action may be due to a number of effects, ranging from inhibition of enzymes such as glycogen synthase kinase 3, inositol phosphatases, or modulation of glutamate receptors.

Mechanism of Action · 1 item

The precise mechanism of action of Li+ as a mood-stabilizing agent is currently unknown. It is possible that Li+ produces its effects by interacting with the transport of monovalent or divalent cations in neurons. An increasing number of scientists have come to the conclusion that the excitatory neurotransmitter glutamate is the key factor in understanding how lithium works. Lithium has been shown to change the inward and outward currents of glutamate receptors (especially GluR3), without a shift in reversal potential. Lithium has been found to exert a dual effect on glutamate receptors, acting to keep the amount of glutamate active between cells at a stable, healthy level, neither too much nor too little. It is postulated that too much glutamate in the space between neurons causes mania, and too little, depression. Another mechanism by which lithium might help to regulate mood include the non-competitive inhibition of an enzyme called inositol monophosphatase. Alternately lithium's action may be enhanced through the deactivation of the GSK-3B enzyme. The regulation of GSK-3B by lithium may affect the circadian clock. GSK-3 is known for phosphorylating and thus inactivating glycogen synthase. GSK-3B has also been implicated in the control of cellular response to damaged DNA. GSK-3 normally phosphorylates beta catenin, which leads to beta catenin degratation. When GSK-3 is inhibited, beta catenin increases and transgenic mice with overexpression of beta catenin express similar behaviour to mice treated with lithium. These results suggest that increase of beta catenin may be a possible pathway for the therapeutic action of lithium.

FDA Pharmacological Classification · 2 items

LITHIUM CITRATE

Mood Stabilizer [EPC]

Uses & manufacturing

Related reactions

8 records
New reaction record
HRID 65823 reaction equation
HRID 65823As reactant
HRID 723276 reaction equation
HRID 723276As reactant
HRID 973242 reaction equation
HRID 973242As reactant
HRID 1029329 reaction equation
HRID 1029329As product
HRID 1155230 reaction equation
HRID 1155230As reactant
HRID 1448432 reaction equation
HRID 1448432As reactant
HRID 1716158 reaction equation
HRID 1716158As reactant
HRID 2250300 reaction equation
HRID 2250300As reactant

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
UNII
3655633623
EC Number
213-045-8、233-819-9、612-032-8、684-184-3
Nikkaji
J48.475J
Adverse EffectsNeurotoxin - Other CNS neurotoxin

Safety data

hs_code
2918150000
UsesUsed as an antidepressant; [Merck Index]
General Manufacturing Information1,2,3-Propanetricarboxylic acid, 2-hydroxy-, lithium salt (1:3): ACTIVE